期刊文献+

己酮可可碱对慢性心力衰竭患者细胞因子的免疫调节及细胞凋亡抑制因子的影响 被引量:2

Effects of pentoxifylline on immune modulatory mechanism of CD^+4Th cells and soluble Fas in patients with congestive heart failure
在线阅读 下载PDF
导出
摘要 目的:探讨己酮可可碱(Pentoxifylline,PTX)对慢性心力衰竭(CHF)患者外周血辅助性T淋巴细胞(Th)免疫调节及血浆细胞凋亡抑制因子(Fas/Apo-1)水平的影响。方法:采用流式细胞术,检测40例心力衰竭(HF)患者和10例正常对照者外周血CD4+Th1和Th2细胞及其分泌的细胞因子干扰素-γ(IFN-γ)和白介素-10(IL-10)的变化。采用ELISA法测定HF患者治疗前后外周血肿瘤坏死因子-α(TNF-α)、IL-10及Fas/Apo-1水平的变化。采用超声心动图检测HF患者射血分数(EF)的变化。结果:HF患者治疗1个月后,PTX治疗组与常规治疗组相比较,分泌IFN-γ的Th1型细胞所占百分比显著降低(P<0.01);而分泌IL-10的Th2型细胞所占百分比明显升高(P<0.01);外周血TNF-α及Fas/Apo-1的水平显著降低(分别为P<0.05和P<0.01);EF显著提高(P<0.01)。结论:HF患者在常规治疗的基础上应用PTX治疗后,EF得到改善,可能与其对HF患者Th1/Th2细胞比例失衡产生的免疫调节作用,以及通过免疫调节影响炎性细胞因子和凋亡抑制因子的激活与分泌有关。 AIM: To investigate the effects of pentoxifylline (FFX) on the immune modulatory mechanism of CD4+ Th and soluble Fas in patients with chronic heart failure (CHF). METHODS : Cytokine- producing Th lymphocytes were quantified by 3-color flow cytometry in 40 CHF patients. Concentrations of TNF-α, IL-10 and Fas/Apo-1 were examined by ELISA, and the ejection fraction was measured by ultrasound echoeardiography. RESULTS: The frequencies of IFN-γ-producing Thl cells were significantly lower and the frequency of IL-10-producing Th2 cells was higher (P 〈 0. 01 ). Levels of TNF-α and Fas/ Apo-1 were lower (P 〈 0. 05, P 〈 0. 01 ) and the ejection fraction was higher in PTX group than those in routine group after 1-month therapy. CONCLUSION: The improvement of ejection fraction resulting from conventional treatment plus pentoxifylline may be related with the effects of pentoxifylline on the immune modulation on Th1/Th2 functional imbalance in CHF patients and on the activation and secretion of inflammatory cytokines and Fas/Apo-1 through immune modulatory mechanisms.
出处 《心脏杂志》 CAS 2011年第4期468-471,共4页 Chinese Heart Journal
关键词 己酮可可碱 慢性心力衰竭 Th1淋巴细胞 Th2淋巴细胞 凋亡抑制因子 免疫调节 pentoxifylline heart failure Thl-lymphocytes Th2-1ymphocytes immunomodulation
  • 相关文献

参考文献4

二级参考文献39

  • 1罗萍,卢永昕,李爱华,刘向阳.己酮可可碱对体外内毒素诱导大鼠心肌细胞生成TNF-α的影响[J].山东医药,2005,45(35):1-2. 被引量:4
  • 2李爱华,卢永昕,罗萍,刘向阳.己酮可可碱对NF-κB介导的新生大鼠心肌细胞凋亡的影响[J].山东医药,2006,46(5):20-21. 被引量:5
  • 3徐玉兰,卢永昕,万建平,刘向阳,荣书玲,米少华,高焱章.己酮可可碱对充血性心力衰竭患者CD_4^+ Th细胞免疫调节的研究[J].临床内科杂志,2007,24(5):301-303. 被引量:4
  • 4Monaco C,Paleolog E.Nuclear factor-κB:a potential therapeutic target in atherosclerosis and thrombosis[J].Cardiovsac Res,2004,61:671-682.
  • 5Bozkurt B, Torre-Amione G, Warren MS, et al. Results of targeted anti-tumor necrosis factor therapy with etanercept(Enbrel) in patients with advanced heart failure[J]. Circulation,2001,103:1044-1047.
  • 6Fichtlscherer S, Rossig L, Breuer S, et al. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure[J]. Circulation, 2001,104 : 3023-3025.
  • 7Coletta AP, Clark AL, Banarjee P, et al. Clinical trials update:RENEWAL (RENAISSANCE and RECOVER) and ATTACH[J]. Eur Heart Fail, 2002,4:559-561.
  • 8Chung ES, Packer M, Lo KM, et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure [J]. Circulation, 2003, 107:3133-3140.
  • 9Anker SD, Coats AJ. How to RECOVER from RENAISSANCE? The significance of results of RECOVER, RENAISSANCE,RENEWAL and ATTACH [J]. Int Cardiol, 2002,86:123-130.
  • 10Staudt A, Landsberger M, Stault Y, et al. Cytokines-eauses,players or bystanders in heart failure [J]. Herz, 2002,27: 691-698.

共引文献8

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部